Literature DB >> 11948374

Introduction of DNA enzyme for Egr-1 into tubulointerstitial fibroblasts by electroporation reduced interstitial alpha-smooth muscle actin expression and fibrosis in unilateral ureteral obstruction (UUO) rats.

H Nakamura1, Y Isaka, M Tsujie, H D Rupprecht, Y Akagi, N Ueda, E Imai, M Hori.   

Abstract

The phenotypic alteration of interstitial fibroblasts into 'myofibroblasts', acquiring characteristics of both fibroblasts and smooth muscle cells is a key event in the formation of tubulointerstitial fibrosis. The up-regulation of the early growth response gene 1 (Egr-1) preceded the increased interstitial expression of alpha-smooth muscle actin (alphaSMA), a marker of phenotypic changes, in obstructed kidney, a model of interstitial fibrosis. To target Egr-1 expression in the interstitium of obstructed kidneys, we introduced a DNA enzyme for Egr-1 (ED5) or scrambled DNA (SCR) into interstitial fibroblasts by electroporation-mediated gene transfer. Northern blot analysis confirmed an increase in the cortical mRNA expression of Egr-1 in the obstructed kidneys from untreated or SCR-treated rats, while ED5 transfection blocked Egr-1 expression with a concomitant reduction in TGF-beta, alphaSMA and type I collagen mRNA expression. Consequently, ED5 inhibited interstitial fibrosis. In conclusion, electroporation-mediated retrograde gene transfer can be an ideal vehicle into interstitial fibroblasts, and molecular intervention of Egr-1 in the interstitium may become a new therapeutic strategy for interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948374     DOI: 10.1038/sj.gt.3301681

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  19 in total

Review 1.  Gene therapy targeting kidney diseases: routes and vehicles.

Authors:  Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

Review 2.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

3.  Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.

Authors:  Clint L Miller; Yujun Cai; Masayoshi Oikawa; Tamlyn Thomas; Wolfgang R Dostmann; Manuela Zaccolo; Keigi Fujiwara; Chen Yan
Journal:  Basic Res Cardiol       Date:  2011-10-20       Impact factor: 17.165

Review 4.  Early growth response-1 in the pathogenesis of cardiovascular disease.

Authors:  Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2016-06-01       Impact factor: 4.599

Review 5.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

6.  Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice.

Authors:  Michele T Pritchard; Laura E Nagy
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

7.  Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Authors:  Kazunori Inoue; Geliang Gan; Maria Ciarleglio; Yan Zhang; Xuefei Tian; Christopher E Pedigo; Corey Cavanaugh; Janet Tate; Ying Wang; Elizabeth Cross; Marwin Groener; Nathan Chai; Zhen Wang; Amy Justice; Zhenhai Zhang; Chirag R Parikh; Francis P Wilson; Shuta Ishibe
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

8.  Egr-1 deficiency protects from renal inflammation and fibrosis.

Authors:  Li-Chun Ho; Junne-Ming Sung; Yi-Ting Shen; Huei-Fen Jheng; Shun-Hua Chen; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  J Mol Med (Berl)       Date:  2016-03-09       Impact factor: 4.599

9.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression.

Authors:  Elizabeth A Nunamaker; Hai-Ying Zhang; Yuichi Shirasawa; Joseph N Benoit; David A Dean
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.